Zobrazeno 1 - 10
of 802
pro vyhledávání: '"SCHERING AG"'
Autor:
Wolfgang Tremel, Lothar Jaenicke, Christian Sowa, Markus Antonietti, Susanne Henke, Lothar Janicke, Christa Hegele-Hartung, Schering Ag
Publikováno v:
Chemie in unserer Zeit. 29:272-281
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::222fbdc2addafb2d64eb0347cb79f9c5
https://doi.org/10.1002/ciuz.19950290507
https://doi.org/10.1002/ciuz.19950290507
Publikováno v:
Advances in Pesticide Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cad6c49ce5d74b01d1d51ce5f86efb5
https://doi.org/10.1016/b978-0-08-023930-9.50396-8
https://doi.org/10.1016/b978-0-08-023930-9.50396-8
The invention relates to indirubin derivatives, which maintain a radically increased solubility while preserving the biological activity at the same time by establishing a quaternary center in the R position. The invention also relates to the product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::5d68d51342e1aea7a24d42f3a3b22a0d
https://register.epo.org/application?number=EP0202983
https://register.epo.org/application?number=EP0202983
The invention refers to the use of a fusion protein comprising an interleukin-2 part and an antibody part, specifically recognising the extra domain B of fibronectin, for treatment of a special form of cancer. Further, the invention refers to a combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::7784fa429fc0265781feff33a0e14547
https://register.epo.org/application?number=EP2007003343
https://register.epo.org/application?number=EP2007003343
The present invention refers to nanoparticles having optically fluorescent activity. In more detail, the invention refers to a nanoparticle matrix comprising a co- aggregate of at least one charged polyelectrolyte and at least one oppositely charged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::d6d8273c55cdcd2ce6383e2dfb0dd806
https://register.epo.org/application?number=EP2006008568
https://register.epo.org/application?number=EP2006008568
The invention relates to a novel solid transdermal therapeutic system which comprises UV absorber and is designed particularly for photosensitive active pharmaceutical substances. Said UV-stable transdermal therapeutic system (TTS) is composed of a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::299d2b5856d99f783ac088ea8cbccf26
https://register.epo.org/application?number=EP2006003959
https://register.epo.org/application?number=EP2006003959
Autor:
SCHERING AG, HUMMEL MARQUARDT HEIDI, KENNECKE MARIO, WEBER ALFRED, SCHMITZ THOMAS, TILSTAM ULF, NICKISCH KLAUS
The invention relates to a process for producing arabino-nucleosides of general formula (I), in which X is a hydrogen atom or a fluorine atom, from triacetates of general formula (II), in which X has the meaning given above and the groups Ac are acet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::10c972a8cc9da400d3b0ec14969fae95
https://register.epo.org/application?number=EP9501343
https://register.epo.org/application?number=EP9501343
Autor:
SCHERING AG
Novel aryl-N-aminoalkyl-4-(sulfonamido)benzamides are described as useful antiarrhytmic agents. Their use in the treatment of cardiac arrhytmias especially as combination class I/class III agents is described. Pharmaceutical formulations containing s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::433d2cbc11841dc45009ca940dbe63fd
https://register.epo.org/application?number=EP8700582
https://register.epo.org/application?number=EP8700582